Alessandro Gronchi (@alegronchi) profile picture

Chair Sarcoma Service - Department of Surgery - National Cancer Institute - Milan - Italy.

Via Venezian 1 20133 Milano IT
Joined January 2014
Photo by Alessandro Gronchi (@alegronchi)Photo by Alessandro Gronchi (@alegronchi)Photo by Alessandro Gronchi (@alegronchi)Photo by Alessandro Gronchi (@alegronchi)Photo by Alessandro Gronchi (@alegronchi)Photo by Alessandro Gronchi (@alegronchi)Photo by Alessandro Gronchi (@alegronchi)Photo by Alessandro Gronchi (@alegronchi)Photo by Alessandro Gronchi (@alegronchi)Photo by Alessandro Gronchi (@alegronchi)
Featured: Well-Differentiated #Liposarcoma of the Psoas Muscle: A Distinct Anatomic Subset with Highly Favorable Outcomes @alegronchi ow.ly/BH9l50ZCGKA @ZaidAbdelsattar @SyedAAhmad5 @SocSurgOnc
4
7
808
Alessandro Gronchi retweeted
The #Sarculator app update is now live! This comes together with our @TheLancetOncol paper introducing #BayeSarc, a Bayesian sequential learning approach to refine prognostication in extremity soft tissue #sarcoma. Paper: sciencedirect.com/science/ar…
App: apps.apple.com/it/app/sarcul…
1
24
2
37
3,958
Alessandro Gronchi retweeted
The challenge of #surgonc is not only technical. It is about generating #evidence, making difficult decisions, organizing care, and keeping #innovation aligned with #patient benefit. @alegronchi opening this conversation @IstTumori at ‘The challenge of surgical oncology’.
6
22
623
Alessandro Gronchi retweeted
Proud to host the ISG–Patient Associations Meeting at #ISG2026. From national networks to legislative progress, today’s program reflects our shared commitment to listen, collaborate, and act for people living with rare tumors. Together, we move beyond paradigms. 💛
2
4
368
Alessandro Gronchi retweeted
The XXIX Annual Meeting of the Italian Sarcoma Group kicks off in Palermo 🇮🇹 250 attendees gathered to share science, collaboration, and new ideas in #sarcoma care. Looking forward to inspiring discussions over the next days! @ItaSarcomaGroup @SilviaStacchia @annamariafrezza
5
13
478
Alessandro Gronchi retweeted
Diagnosis and treatment of primary soft tissue sarcomas: comprehensive review ➡️doi.org/10.1093/bjsopen/zraf… This review outlines current diagnostic and treatment strategies for localized primary soft tissue sarcomas, with a separate focus on extremity/trunk and retroperitoneal disease. Key points include recent therapeutic advances, multidisciplinary management, and the centralization of care in high-volume centres to optimize outcomes. 👏👏👏Fahima Dossa , Eldad Elnekave , Aisha B Miah , Catherine Mitchell , Sarah Watson , @alegronchi , @FioreDoc #SoMe4Surgery #MedTwitter #SurgEd #Surgery @BJSAcademy @BJSurgery
24
2
49
4,481
Alessandro Gronchi retweeted
Want to join us? Register for free membership at tarpswg.org And save the date for next meeting in November 2026 in Seoul (in connection with @ctosociety meeting)
4
6
712
Alessandro Gronchi retweeted
#Guidelines update for primary RPS planned for 2028 New #Guidelines specific for pelvic sarcoma underway #ERAS projects to define official protocols for RPS
1
1
6
478
Alessandro Gronchi retweeted
Much to come for #retroperitoneal #sarcoma: #STRASS3 for neoadjuvant tx in LPS will include ICI? #RESAR registry now includes >3800 pts and new analyses are ongoing #Delphi consensus to standardize terminology and approach to RPS expected in 2027
1
3
8
553
Alessandro Gronchi retweeted
TARPSWG Meeting was successful once again this year! Thanks to #SSO2026 for hosting us in Phoenix 🌵🌵😀
1
7
12
1,380
Alessandro Gronchi retweeted
Great to be in Phoenix for #SSO2026. Connecting with Sug Oncs worldwide amazing as always @alegronchi
3
15
529
Thanks for coming over. It was great to spend some time together!
Sarcoma family dinner 💛thank you @SilviaStacchia and @alegronchi for welcoming us into your home, workplace and international sarcoma family! @TARPSWG @ctosociety @UofTSurgOnc
1
14
985
1/ 🚨 When surgery is not enough: time to rethink patient selection in #retroperitoneal #sarcoma. Are we operating on tumor biology we don’t yet understand? In primary RPS, ~20% of patients recur within 6 months after surgery — with survival comparable to unresected patients.
1
12
17
1,909
4/ The future is not just better surgery — it’s better selection: 🔬 biomarkers 🧠 AI prediction 💊 smarter neoadjuvant strategies
1
3
6
649
Alessandro Gronchi retweeted
Capire meglio i sarcomi, ascoltare esperti e testimonianze, scoprire il ruolo delle associazioni nella ricerca e nel supporto dei Pazienti: @ segui in streaming 👉 teams.microsoft.com/l/meetup… @FondFerrero @fumagallielena_ @alegronchi @SilviaStacchia @DAmbrosio_MD
3
4
487
Alessandro Gronchi retweeted
When p > 0.05 is not the end of the conversation. Fantastic Grand Round by @fdossa on how statistical misunderstandings can shape (and misshape) treatment decisions. A must-hear for clinicians. #sarcoma #clinicaltrials #statistics #oncology #surgery
1
5
1
17
1,972